Abstract
In 1968 25-hydroxyvitamin D3 (25-OH-D3) was isolated in pure form and chemically identified (4). During the ensuing years it was demonstrated that this hydroxylation occurs in the liver prior to the initiation of intestinal calcium transport or bone calcium mobilization (20, 5). Following this initial demonstration that vitamin D is not active as such but must be metabolically altered before it can function, it was soon learned that a metabolite of vitamin D more polar than 25-OH-D3 appeared in the target tissues prior to response (19, 17, 9). This conversion was demonstrated by Fraser and Kodicek to occur in the kidney (8). In 1970 and 1971 this compound was isolated in pure form and identified as 1,25-dihydroxyvitamin D3 (1,25-(OH)2 D3) (12). It was subsequently synthesized to confirm its structure and to provide evidence for the la configuration for the hydroxyl placed on ring A (22). During the course of this synthesis an important new analog was prepared, namely la-hydroxyvitamin D3 (lα-OH-D3) (13) (Fig. 1). Perhaps not surprising in retrospect is the fact that this compound proved to be almost equally as active as 1,25-(OH)2 D3 in the chick (10) but approximately one-half as active as the natural metabolite in the rat (14). The time course of onset of responses to the lα-OH-D3 was remarkably similar to the 1,25-(OH)2 D3 (13) and in the case of the chick (10), virtually identical. Of great interest was the fact that the lα-OH-D3 was much more effective when given in oil solutions orally to the rat than was the corresponding 1,25-(OH)2 D3, leading to the idea that perhaps the lα-OH-D3 in some species is more easily absorbed (14). Its ease of synthesis (13, 2, 16) and the relative inexpensiveness of the starting material led to its application to such diseases as chronic renal failure and hypoparathyroidism in which there is a clear indication of impared ability to carry out the 1-hydroxylation of 25-OH-D3. This has met with marked success in virtually every clinical center (6, 1, 7, 21). However, the surprising fact that the lα-OH-D3 produced a response almost identical in time course to the 1,25-(OH)2 D3 in animals led to the suggestion that lα-OH-D3 might function without the necessity of 25-hydroxylation. On the other hand it also seemed possible that the lα-OH-D3 might be hydroxylated on carbon 25 very rapidly. Although work by Zerwekh et al. (26) indicated that 25-hydroxylation of lα-OH-D3 does take place in the chick, the methods used to detect 1,25-(OH)2 D3 were indirect and not conclusive as they themselves stated.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Balsan, S., Garabedian, M., Pezant, E., Sorgniard, R., Holick, M.F. and DeLuca, H.F.: Biologic and therapeutic effects of la-hydroxyvitamin D in children. In: Calcium Regulating Hormones. Talmage, R.V., Owen, M. and Parsons, J.A. (eds.), Excerpta Medica, Amsterdam, pp 439–447, 1975
Barton, D.H.R., Hesse, R.H., Pechet, M.M. and Rizzardo, E.: A convenient synthesis of la-hydroxyvitamin D3. J. Amer. chem. Soc. 95, 2748–2749 (1973)
Bhattacharyya, M. and DeLuca, H.F.: Subcellular location of rat liver calciferol-25hydroxylase. Arch. Biochem. 160, 58–62 (1974)
Blunt, J.W., DeLuca, H.F. and Schnoes, H.K.: 25-Hydroxycholecalciferol. A biologically active metabolite of vitamin D3. Biochemistry 7, 3317–3322 (1968)
Blunt, J.W., Tanaka, Y. Y DeLuca, H.F.: The Biological Activity of 25-Hydroxycholecalciferol, a metabolite of vitamin D3. Proc. nat. Acad. Sci. (Wash.) 61, 1503–1506 (1968)
Chalmers, T.M., Davie, M.W., Hunter, J.O., Szaz, K.F., Pelc, B. and Kodicek, E.: la-Hydroxycholecalciferol as a substitute for the kidney hormone 1,25dihydroxycholecalciferol in chronic renal failure. Lancet (1973), ii, 696–699
Chan, J.C.M., Oldham, S.B., Holick, M.F. and DeLuca, H.F.: la-Hydroxyvitamin D3 in chronic renal failure. J. Am. Med. Assoc. 234, 47–52 (1975)
Fraser, D.R. and Kodicek, E.: Unique biosynthesis by kidney of a biologically active vitamin D metabolite. Nature 228, 764–766 (1970)
Haussler, M.R., Myrtle, J.F. and Norman, A.W.: The association of a metabolite of vitamin D3 with intestinal mucosa chromatin in vivo. J. Biol. Chem. 243, 4055–4064 (1968)
Haussier, M.R., Zerwekh, J.E., Hesse, R.H., Rizzardo, E. and Pechet, M.M.: Biological activity of la-hydroxycholecalciferol, a synthetic analog of the hormonal form of vitamin D3. Proc. nat. Acad. Sci. (Wash.) 70, 2248–2252 (1973)
Holick, M.F. and DeLuca, H.F.: A new chromatographic system for vitamin D3 and its metabolites: Resolution of a new vitamin D3 metabolite. J. Lipid Res. 12, 460–465 (1971)
Holick, M.F., Schnoes, H.K., DeLuca, H.F., Suda, T. and Cousins, R J.: Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine. Biochemistry 10, 2799–2804 (1971)
Holick, M.F., Semmler, E J., Schnoes, H.K. and DeLuca, H.F.: la-hydroxy derivative of vitamin D3: A highly potent analog of 1CY,25-dihydroxyvitamin D3. Science 180, 190–191 (1973)
Holick, M.F., Kasten-Schraufrogel, P., Tavela, T. and DeLuca, H.F.: Biological activity of la-hydroxyvitamin D3 in the rat. Arch. Biochem. 166, 63–66 (1975)
Hulick, M.F., Holick, S.A., Tavela, T., Gallagher, B., Schnoes, H.K. and DeLuca, H.F.: Synthesis of [6–3H]-1CY-hydroxyvitamin D3 and its metabolism in vivo to [3H]-la,25-dihydroxyvitamin D3. Science 190, 576–578 (1975)
Kaneko, C., Yamada, S., Sugimoto, A., Eguchi, Y., Ishikawa, M., Suda, T., Suzuki, M., Kakuta, S. and Sasaki, S.: Synthesis and biological activity of la-hydroxyvitamin D3. Steroids 23, 75–92 (1974)
Lawson, D.E.M., Wilson, P.W. and Kodicek, E.: Metabolism of vitamin D. A new cholecalciferol metabolite, involving loss of hydrogen at C-1, in chick intestinal nuclei. Biochem. J. 115, 269–277 (1969)
Maclaren, N. and Lifshitz, F.: Vitamin D-dependency rickets in institutionalized, mentally retarded children on long term anticonvulsant therapy. II. The response to 25-hydroxycholecalciferol and to vitamin D3. Pediat. Res. 7, 914–922 (1973)
Ponchon, G. and DeLuca, H.F.: Metabolites of vitamin D3 and their biological activity. J. Nutr. 99, 157–167 (1969)
Ponchon, G., Kennan, A.L. and DeLuca, H.F.: “Activation” of vitamin D by the liver. J. clin. Invest. 48, 2032–2037 (1969)
Reade, T.M., Scriver, C.R., Glorieux, F.H., Nogrady, B., Delvin, E., Poirier, R., Holick, M.F. and DeLuca, H.F.: Response to crystalline la-hydroxy vitamin D3 in vitamin D dependency. Pediat. Res. 9, 593–599 (1975)
Semmler, E J., Holick, M.F., Schnoes, H.K. and DeLuca, H.F.: The synthesis of I01,25-dihydroxycholecalciferol. A metabolically active form of vitamin D3. Tetrahedron Letters 40, 4147–4150 (1972)
Stamp, T.C.B., Round, J.M., Rowe, D.J.F. and Haddad, J.G.: Plasma levels and therapeutic effect of 25-hydroxycholecalciferol in epileptic patients taking anticonvulsant drugs. Brit. Med. J. 4, 9–12 (1972)
Toffolon, E.P., Pechet, M.M. and Isselbacher, K.: Demonstration of the rapid action of pure crystalline la-hydroxy vitamin D3 and la,25-dihydroxy vitamin D3 on intestinal calcium uptake. Proc. nat. Acad. Sci. (Wash.) 72, 229–230 (1975)
Tucker, G., Gagnon, R.E. and Haussier, M.R.: Vitamin D3–25-hydroxylase: Tissue occurrence and apparent lack of regulation. Arch. Biochem. 155, 47–57 (1973)
Zerwekh, J.E., Brumbaugh, P.F., Haussier, D.H., Cork, DJ. and Haussler, M.R.: la-Hydroxyvitamin D3. An analog of vitamin D which apparently acts by metabolism to la,25-dihydroxyvitamin D3. Biochemistry 13, 4097–4102 (1974)
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1976 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
DeLuca, H.F., Holick, S.A., Holick, M.F. (1976). The Metabolism and Function of 1α-Hydroxyvitamin D3 . In: Nielsen, S.P., Hjørting-Hansen, E. (eds) Calcified Tissues 1975. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-29272-3_19
Download citation
DOI: https://doi.org/10.1007/978-3-662-29272-3_19
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-27776-8
Online ISBN: 978-3-662-29272-3
eBook Packages: Springer Book Archive